APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Plasma and Serum Proteomics Analysis Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Plasma and Serum Proteomics Analysis Service Market Analysis and Forecast 2026-2032

Report ID 174530080512 August 2026193 pages

Choose your research edition.

Industry ResearchPlasma and Serum Proteomics Analysis Service Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Plasma and Serum Proteomics Analysis Service Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Plasma and Serum Proteomics Analysis Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plasma and Serum Proteomics Analysis Service Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Plasma and Serum Proteomics Analysis Service Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Plasma and Serum Proteomics Analysis Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Plasma and Serum Proteomics Analysis Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Plasma and Serum Proteomics Analysis Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Plasma and Serum Proteomics Analysis Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Plasma and Serum Proteomics Analysis Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Plasma and Serum Proteomics Analysis Service include BostonGene, CellCarta, GENEWIZ (Azenta Life Sciences), CDI Labs, Biognosys, Discovery Life Sciences, Firalis Molecular Precision, Cell Signaling Technology (CST) and Sampled (Infinity Biologix), etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Plasma and Serum Proteomics Analysis Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Plasma and Serum Proteomics Analysis Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Plasma and Serum Proteomics Analysis Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Plasma and Serum Proteomics Analysis Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Plasma and Serum Proteomics Analysis Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Plasma and Serum Proteomics Analysis Service revenue, projected growth trends, production technology, application and end-user industry.

Plasma and Serum Proteomics Analysis Service Segment by Company

BostonGene

CellCarta

GENEWIZ (Azenta Life Sciences)

CDI Labs

Biognosys

Discovery Life Sciences

Firalis Molecular Precision

Cell Signaling Technology (CST)

Sampled (Infinity Biologix)

APTBIO

Sinotech Genomics

Biodesix

Panome Bio

Novogene

PTM BIO

BGI Genomics

Evotec

Metware Biotechnology

MRM Proteomics

Lc-Bio Technologies

Eurofins Scientific

MtoZ-Biolabs

Creative Proteomics

Macrogen

TATAA Biocenter

OmicScouts (Momentum Biotechnologies)

Precision Biomarker Laboratories (PBL)

Shanghai OE Biotech

RxCelerate

Proteomics International

Proteome Sciences

Westlake Omics

Crown Bioscience

VProteomics

Shanghai Majorbio Bio-Pharm

Applied Biomics

Sapient Bioanalytics

Allumiqs

MS Bioworks

Shanghai Bioprofile

Cosmos Wisdom

Olink (Thermo Fisher Scientific)

SomaLogic (Illumina)

Labcorp

Plasma and Serum Proteomics Analysis Service Segment by Type

Plasma Proteomics Analysis Service

Serum Proteomics Analysis Service

Plasma and Serum Proteomics Analysis Service Segment by Application

Disease Biomarker Research

Drug Development

Clinical Research

Others

Plasma and Serum Proteomics Analysis Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma and Serum Proteomics Analysis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plasma and Serum Proteomics Analysis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma and Serum Proteomics Analysis Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Plasma and Serum Proteomics Analysis Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Plasma and Serum Proteomics Analysis Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Plasma and Serum Proteomics Analysis Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Plasma and Serum Proteomics Analysis Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Plasma Proteomics Analysis Service Major Player Table 3. Serum Proteomics Analysis Service Major Player Table 4. Global Plasma and Serum Proteomics Analysis Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Disease Biomarker Research Major Player Table 6. Drug Development Major Player Table 7. Clinical Research Major Player Table 8. Others Major Player Table 9. Plasma and Serum Proteomics Analysis Service Industry Trends Table 10. Plasma and Serum Proteomics Analysis Service Industry Drivers Table 11. Plasma and Serum Proteomics Analysis Service Industry Opportunities and Challenges Table 12. Plasma and Serum Proteomics Analysis Service Industry Restraints Table 13. Global Plasma and Serum Proteomics Analysis Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Plasma and Serum Proteomics Analysis Service Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Plasma and Serum Proteomics Analysis Service Market Share by Region (2021-2026) Table 16. Global Plasma and Serum Proteomics Analysis Service Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Plasma and Serum Proteomics Analysis Service Market Share by Region (2027-2032) Table 18. Global Plasma and Serum Proteomics Analysis Service Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Plasma and Serum Proteomics Analysis Service Revenue Market Share by Players (2021-2026) Table 20. Global Plasma and Serum Proteomics Analysis Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Plasma and Serum Proteomics Analysis Service Key Players Headquarters & Area Served Table 22. Global Plasma and Serum Proteomics Analysis Service Players, Product Type & Application Table 23. Global Plasma and Serum Proteomics Analysis Service Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Plasma and Serum Proteomics Analysis Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Plasma and Serum Proteomics Analysis Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Plasma and Serum Proteomics Analysis Service Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Plasma and Serum Proteomics Analysis Service Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Plasma and Serum Proteomics Analysis Service Revenue Market Share by Type (2021-2026) Table 30. Global Plasma and Serum Proteomics Analysis Service Revenue Market Share by Type (2027-2032) Table 31. Global Plasma and Serum Proteomics Analysis Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Plasma and Serum Proteomics Analysis Service Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Plasma and Serum Proteomics Analysis Service Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Plasma and Serum Proteomics Analysis Service Revenue Market Share by Application (2021-2026) Table 35. Global Plasma and Serum Proteomics Analysis Service Revenue Market Share by Application (2027-2032) Table 36. BostonGene Company Information Table 37. BostonGene Business Overview Table 38. BostonGene Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. BostonGene Plasma and Serum Proteomics Analysis Service Product Portfolio Table 40. BostonGene Recent Development Table 41. CellCarta Company Information Table 42. CellCarta Business Overview Table 43. CellCarta Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. CellCarta Plasma and Serum Proteomics Analysis Service Product Portfolio Table 45. CellCarta Recent Development Table 46. GENEWIZ (Azenta Life Sciences) Company Information Table 47. GENEWIZ (Azenta Life Sciences) Business Overview Table 48. GENEWIZ (Azenta Life Sciences) Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. GENEWIZ (Azenta Life Sciences) Plasma and Serum Proteomics Analysis Service Product Portfolio Table 50. GENEWIZ (Azenta Life Sciences) Recent Development Table 51. CDI Labs Company Information Table 52. CDI Labs Business Overview Table 53. CDI Labs Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. CDI Labs Plasma and Serum Proteomics Analysis Service Product Portfolio Table 55. CDI Labs Recent Development Table 56. Biognosys Company Information Table 57. Biognosys Business Overview Table 58. Biognosys Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Biognosys Plasma and Serum Proteomics Analysis Service Product Portfolio Table 60. Biognosys Recent Development Table 61. Discovery Life Sciences Company Information Table 62. Discovery Life Sciences Business Overview Table 63. Discovery Life Sciences Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Discovery Life Sciences Plasma and Serum Proteomics Analysis Service Product Portfolio Table 65. Discovery Life Sciences Recent Development Table 66. Firalis Molecular Precision Company Information Table 67. Firalis Molecular Precision Business Overview Table 68. Firalis Molecular Precision Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Firalis Molecular Precision Plasma and Serum Proteomics Analysis Service Product Portfolio Table 70. Firalis Molecular Precision Recent Development Table 71. Cell Signaling Technology (CST) Company Information Table 72. Cell Signaling Technology (CST) Business Overview Table 73. Cell Signaling Technology (CST) Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Cell Signaling Technology (CST) Plasma and Serum Proteomics Analysis Service Product Portfolio Table 75. Cell Signaling Technology (CST) Recent Development Table 76. Sampled (Infinity Biologix) Company Information Table 77. Sampled (Infinity Biologix) Business Overview Table 78. Sampled (Infinity Biologix) Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Sampled (Infinity Biologix) Plasma and Serum Proteomics Analysis Service Product Portfolio Table 80. Sampled (Infinity Biologix) Recent Development Table 81. APTBIO Company Information Table 82. APTBIO Business Overview Table 83. APTBIO Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. APTBIO Plasma and Serum Proteomics Analysis Service Product Portfolio Table 85. APTBIO Recent Development Table 86. Sinotech Genomics Company Information Table 87. Sinotech Genomics Business Overview Table 88. Sinotech Genomics Plasma and Serum Proteomics Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Sinotech Genomics Plasma and Serum Proteomics Analysis Service Product Portfolio Table 90. Sinotech Genomics Recent Development Table 91. Biodesix Company Information Table 92. Biodesix Business Overview Table 93. Biodesix Plasma and Serum Proteomics Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Biodesix Plasma and Serum Proteomics Analysis Service Product Portfolio Table 95. Biodesix Recent Development Table 96. Panome Bio Company Information Table 97. Panome Bio Business Overview Table 98. Panome Bio Plasma and Serum Proteomics Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Panome Bio Plasma and Serum Proteomics Analysis Service Product Portfolio Table 100. Panome Bio Recent Development Table 101. Novogene Company Information Table 102. Novogene Business Overview Table 103. Novogene Plasma and Serum Proteomics Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Novogene Plasma and Serum Proteomics Analysis Service Product Portfolio Table 105. Novogene Recent Development Table 106. PTM BIO Company Information Table 107. PTM BIO Business Overview Table 108. PTM BIO Plasma and Serum Proteomics Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. PTM BIO Plasma and Serum Proteomics Analysis Service Product Portfolio Table 110. PTM BIO Recent Development Table 111. BGI Genomics Company Information Table 112. BGI Genomics Business Overview Table 113. BGI Genomics Plasma and Serum Proteomics Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. BGI Genomics Plasma and Serum Proteomics Analysis Service Product Portfolio Table 115. BGI Genomics Recent Development Table 116. Evotec Company Information Table 117. Evotec Business Overview Table 118. Evotec Plasma and Serum Proteomics Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Evotec Plasma and Serum Proteomics Analysis Service Product Portfolio Table 120. Evotec Recent Development Table 121. Metware Biotechnology Company Information Table 122. Metware Biotechnology Business Overview Table 123. Metware Biotechnology Plasma and Serum Proteomics Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Metware Biotechnology Plasma and Serum Proteomics Analysis Service Product Portfolio Table 125. Metware Biotechnology Recent Development Table 126. MRM Proteomics Company Information Table 127. MRM Proteomics Business Overview Table 128. MRM Proteomics Plasma and Serum Proteomics Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. MRM Proteomics Plasma and Serum Proteomics Analysis Service Product Portfolio Table 130. MRM Proteomics Recent Development Table 131. Lc-Bio Technologies Company Information Table 132. Lc-Bio Technologies Business Overview Table 133. Lc-Bio Technologies Plasma and Serum Proteomics Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Lc-Bio Technologies Plasma and Serum Proteomics Analysis Service Product Portfolio Table 135. Lc-Bio Technologies Recent Development Table 136. Eurofins Scientific Company Information Table 137. Eurofins Scientific Business Overview Table 138. Eurofins Scientific Plasma and Serum Proteomics Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Eurofins Scientific Plasma and Serum Proteomics Analysis Service Product Portfolio Table 140. Eurofins Scientific Recent Development Table 141. MtoZ-Biolabs Company Information Table 142. MtoZ-Biolabs Business Overview Table 143. MtoZ-Biolabs Plasma and Serum Proteomics Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. MtoZ-Biolabs Plasma and Serum Proteomics Analysis Service Product Portfolio Table 145. MtoZ-Biolabs Recent Development Table 146. Creative Proteomics Company Information Table 147. Creative Proteomics Business Overview Table 148. Creative Proteomics Plasma and Serum Proteomics Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. Creative Proteomics Plasma and Serum Proteomics Analysis Service Product Portfolio Table 150. Creative Proteomics Recent Development Table 151. Macrogen Company Information Table 152. Macrogen Business Overview Table 153. Macrogen Plasma and Serum Proteomics Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 154. Macrogen Plasma and Serum Proteomics Analysis Service Product Portfolio Table 155. Macrogen Recent Development Table 156. TATAA Biocenter Company Information Table 157. TATAA Biocenter Business Overview Table 158. TATAA Biocenter Plasma and Serum Proteomics Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 159. TATAA Biocenter Plasma and Serum Proteomics Analysis Service Product Portfolio Table 160. TATAA Biocenter Recent Development Table 161. OmicScouts (Momentum Biotechnologies) Company Information Table 162. OmicScouts (Momentum Biotechnologies) Business Overview Table 163. OmicScouts (Momentum Biotechnologies) Plasma and Serum Proteomics Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 164. OmicScouts (Momentum Biotechnologies) Plasma and Serum Proteomics Analysis Service Product Portfolio Table 165. OmicScouts (Momentum Biotechnologies) Recent Development Table 166. Precision Biomarker Laboratories (PBL) Company Information Table 167. Precision Biomarker Laboratories (PBL) Business Overview Table 168. Precision Biomarker Laboratories (PBL) Plasma and Serum Proteomics Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 169. Precision Biomarker Laboratories (PBL) Plasma and Serum Proteomics Analysis Service Product Portfolio Table 170. Precision Biomarker Laboratories (PBL) Recent Development Table 171. Shanghai OE Biotech Company Information Table 172. Shanghai OE Biotech Business Overview Table 173. Shanghai OE Biotech Plasma and Serum Proteomics Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 174. Shanghai OE Biotech Plasma and Serum Proteomics Analysis Service Product Portfolio Table 175. Shanghai OE Biotech Recent Development Table 176. RxCelerate Company Information Table 177. RxCelerate Business Overview Table 178. RxCelerate Plasma and Serum Proteomics Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 179. RxCelerate Plasma and Serum Proteomics Analysis Service Product Portfolio Table 180. RxCelerate Recent Development Table 181. Proteomics International Company Information Table 182. Proteomics International Business Overview Table 183. Proteomics International Plasma and Serum Proteomics Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 184. Proteomics International Plasma and Serum Proteomics Analysis Service Product Portfolio Table 185. Proteomics International Recent Development Table 186. Proteome Sciences Company Information Table 187. Proteome Sciences Business Overview Table 188. Proteome Sciences Plasma and Serum Proteomics Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 189. Proteome Sciences Plasma and Serum Proteomics Analysis Service Product Portfolio Table 190. Proteome Sciences Recent Development Table 191. Westlake Omics Company Information Table 192. Westlake Omics Business Overview Table 193. Westlake Omics Plasma and Serum Proteomics Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 194. Westlake Omics Plasma and Serum Proteomics Analysis Service Product Portfolio Table 195. Westlake Omics Recent Development Table 196. Crown Bioscience Company Information Table 197. Crown Bioscience Business Overview Table 198. Crown Bioscience Plasma and Serum Proteomics Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 199. Crown Bioscience Plasma and Serum Proteomics Analysis Service Product Portfolio Table 200. Crown Bioscience Recent Development Table 201. VProteomics Company Information Table 202. VProteomics Business Overview Table 203. VProteomics Plasma and Serum Proteomics Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 204. VProteomics Plasma and Serum Proteomics Analysis Service Product Portfolio Table 205. VProteomics Recent Development Table 206. Shanghai Majorbio Bio-Pharm Company Information Table 207. Shanghai Majorbio Bio-Pharm Business Overview Table 208. Shanghai Majorbio Bio-Pharm Plasma and Serum Proteomics Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 209. Shanghai Majorbio Bio-Pharm Plasma and Serum Proteomics Analysis Service Product Portfolio Table 210. Shanghai Majorbio Bio-Pharm Recent Development Table 211. Applied Biomics Company Information Table 212. Applied Biomics Business Overview Table 213. Applied Biomics Plasma and Serum Proteomics Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 214. Applied Biomics Plasma and Serum Proteomics Analysis Service Product Portfolio Table 215. Applied Biomics Recent Development Table 216. Sapient Bioanalytics Company Information Table 217. Sapient Bioanalytics Business Overview Table 218. Sapient Bioanalytics Plasma and Serum Proteomics Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 219. Sapient Bioanalytics Plasma and Serum Proteomics Analysis Service Product Portfolio Table 220. Sapient Bioanalytics Recent Development Table 221. Allumiqs Company Information Table 222. Allumiqs Business Overview Table 223. Allumiqs Plasma and Serum Proteomics Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 224. Allumiqs Plasma and Serum Proteomics Analysis Service Product Portfolio Table 225. Allumiqs Recent Development Table 226. MS Bioworks Company Information Table 227. MS Bioworks Business Overview Table 228. MS Bioworks Plasma and Serum Proteomics Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 229. MS Bioworks Plasma and Serum Proteomics Analysis Service Product Portfolio Table 230. MS Bioworks Recent Development Table 231. Shanghai Bioprofile Company Information Table 232. Shanghai Bioprofile Business Overview Table 233. Shanghai Bioprofile Plasma and Serum Proteomics Analysis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 234. Shanghai Bioprofile Plasma and Serum Proteomics Analysis Service Product Portfolio Table 235. Shanghai Bioprofile Recent Development Table 236. North America Plasma and Serum Proteomics Analysis Service Revenue by Type (2021-2026) & (US$ Million) Table 237. North America Plasma and Serum Proteomics Analysis Service Revenue by Type (2027-2032) & (US$ Million) Table 238. North America Plasma and Serum Proteomics Analysis Service Revenue by Application (2021-2026) & (US$ Million) Table 239. North America Plasma and Serum Proteomics Analysis Service Revenue by Application (2027-2032) & (US$ Million) Table 240. North America Plasma and Serum Proteomics Analysis Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 241. North America Plasma and Serum Proteomics Analysis Service Revenue by Country (2021-2026) & (US$ Million) Table 242. North America Plasma and Serum Proteomics Analysis Service Revenue by Country (US$ Million) & (2027-2032) Table 243. Europe Plasma and Serum Proteomics Analysis Service Revenue by Type (2021-2026) & (US$ Million) Table 244. Europe Plasma and Serum Proteomics Analysis Service Revenue by Type (2027-2032) & (US$ Million) Table 245. Europe Plasma and Serum Proteomics Analysis Service Revenue by Application (2021-2026) & (US$ Million) Table 246. Europe Plasma and Serum Proteomics Analysis Service Revenue by Application (2027-2032) & (US$ Million) Table 247. Europe Plasma and Serum Proteomics Analysis Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 248. Europe Plasma and Serum Proteomics Analysis Service Revenue by Country (2021-2026) & (US$ Million) Table 249. Europe Plasma and Serum Proteomics Analysis Service Revenue by Country (US$ Million) & (2027-2032) Table 250. China Plasma and Serum Proteomics Analysis Service Revenue by Type (2021-2026) & (US$ Million) Table 251. China Plasma and Serum Proteomics Analysis Service Revenue by Type (2027-2032) & (US$ Million) Table 252. China Plasma and Serum Proteomics Analysis Service Revenue by Application (2021-2026) & (US$ Million) Table 253. China Plasma and Serum Proteomics Analysis Service Revenue by Application (2027-2032) & (US$ Million) Table 254. Asia Plasma and Serum Proteomics Analysis Service Revenue by Type (2021-2026) & (US$ Million) Table 255. Asia Plasma and Serum Proteomics Analysis Service Revenue by Type (2027-2032) & (US$ Million) Table 256. Asia Plasma and Serum Proteomics Analysis Service Revenue by Application (2021-2026) & (US$ Million) Table 257. Asia Plasma and Serum Proteomics Analysis Service Revenue by Application (2027-2032) & (US$ Million) Table 258. Asia Plasma and Serum Proteomics Analysis Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 259. Asia Plasma and Serum Proteomics Analysis Service Revenue by Region (US$ Million) & (2021-2026) Table 260. Asia Plasma and Serum Proteomics Analysis Service Revenue by Region (US$ Million) & (2027-2032) Table 261. SAMEA Plasma and Serum Proteomics Analysis Service Revenue by Type (2021-2026) & (US$ Million) Table 262. SAMEA Plasma and Serum Proteomics Analysis Service Revenue by Type (2027-2032) & (US$ Million) Table 263. SAMEA Plasma and Serum Proteomics Analysis Service Revenue by Application (2021-2026) & (US$ Million) Table 264. SAMEA Plasma and Serum Proteomics Analysis Service Revenue by Application (2027-2032) & (US$ Million) Table 265. SAMEA Plasma and Serum Proteomics Analysis Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 266. SAMEA Plasma and Serum Proteomics Analysis Service Revenue by Country (2021-2026) & (US$ Million) Table 267. SAMEA Plasma and Serum Proteomics Analysis Service Revenue by Country (US$ Million) & (2027-2032) Table 268. Research Programs/Design for This Report Table 269. Authors List of This Report Table 270. Secondary Sources Table 271. Primary Sources List of Figures Figure 1. Plasma and Serum Proteomics Analysis Service Image Figure 2. Global Plasma and Serum Proteomics Analysis Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Plasma and Serum Proteomics Analysis Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Plasma Proteomics Analysis Service Image Figure 5. Serum Proteomics Analysis Service Image Figure 6. Global Plasma and Serum Proteomics Analysis Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Plasma and Serum Proteomics Analysis Service Market Size Share 2021 VS 2025 VS 2032 Figure 8. Disease Biomarker Research Image Figure 9. Drug Development Image Figure 10. Clinical Research Image Figure 11. Others Image Figure 12. Global Plasma and Serum Proteomics Analysis Service Market Size (US$ Million) & (2021-2032) Figure 13. Global Plasma and Serum Proteomics Analysis Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Plasma and Serum Proteomics Analysis Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Plasma and Serum Proteomics Analysis Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Plasma and Serum Proteomics Analysis Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Plasma and Serum Proteomics Analysis Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Plasma and Serum Proteomics Analysis Service Revenue Market Share by Type (2021-2032) Figure 20. Global Plasma and Serum Proteomics Analysis Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Plasma and Serum Proteomics Analysis Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Plasma and Serum Proteomics Analysis Service Revenue Market Share by Application (2021-2032) Figure 23. North America Plasma and Serum Proteomics Analysis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Plasma and Serum Proteomics Analysis Service Revenue Share by Type (2021-2032) Figure 25. North America Plasma and Serum Proteomics Analysis Service Revenue Share by Application (2021-2032) Figure 26. North America Plasma and Serum Proteomics Analysis Service Revenue Share by Country (2021-2032) Figure 27. United States Plasma and Serum Proteomics Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Plasma and Serum Proteomics Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Plasma and Serum Proteomics Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Plasma and Serum Proteomics Analysis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Plasma and Serum Proteomics Analysis Service Revenue Share by Type (2021-2032) Figure 32. Europe Plasma and Serum Proteomics Analysis Service Revenue Share by Application (2021-2032) Figure 33. Europe Plasma and Serum Proteomics Analysis Service Revenue Share by Country (2021-2032) Figure 34. Germany Plasma and Serum Proteomics Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Plasma and Serum Proteomics Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Plasma and Serum Proteomics Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Plasma and Serum Proteomics Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Plasma and Serum Proteomics Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Plasma and Serum Proteomics Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Plasma and Serum Proteomics Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Plasma and Serum Proteomics Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Plasma and Serum Proteomics Analysis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Plasma and Serum Proteomics Analysis Service Revenue Share by Type (2021-2032) Figure 44. China Plasma and Serum Proteomics Analysis Service Revenue Share by Application (2021-2032) Figure 45. Asia Plasma and Serum Proteomics Analysis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Plasma and Serum Proteomics Analysis Service Revenue Share by Type (2021-2032) Figure 47. Asia Plasma and Serum Proteomics Analysis Service Revenue Share by Application (2021-2032) Figure 48. Asia Plasma and Serum Proteomics Analysis Service Revenue Share by Region (2021-2032) Figure 49. Japan Plasma and Serum Proteomics Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Plasma and Serum Proteomics Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Plasma and Serum Proteomics Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Plasma and Serum Proteomics Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Plasma and Serum Proteomics Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Plasma and Serum Proteomics Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Plasma and Serum Proteomics Analysis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Plasma and Serum Proteomics Analysis Service Revenue Share by Type (2021-2032) Figure 57. SAMEA Plasma and Serum Proteomics Analysis Service Revenue Share by Application (2021-2032) Figure 58. SAMEA Plasma and Serum Proteomics Analysis Service Revenue Share by Country (2021-2032) Figure 59. Brazil Plasma and Serum Proteomics Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Plasma and Serum Proteomics Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Plasma and Serum Proteomics Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Plasma and Serum Proteomics Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Plasma and Serum Proteomics Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Plasma and Serum Proteomics Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Plasma and Serum Proteomics Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Plasma and Serum Proteomics Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Plasma and Serum Proteomics Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Plasma and Serum Proteomics Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Plasma and Serum Proteomics Analysis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Plasma Proteomics Analysis Service
  • Serum Proteomics Analysis Service
Applications
  • Disease Biomarker Research
  • Drug Development
  • Clinical Research
  • Others
Companies covered
  • BostonGene
  • CellCarta
  • GENEWIZ (Azenta Life Sciences)
  • CDI Labs
  • Biognosys
  • Discovery Life Sciences
  • Firalis Molecular Precision
  • Cell Signaling Technology (CST)
  • Sampled (Infinity Biologix)
  • APTBIO
  • Sinotech Genomics
  • Biodesix
  • Panome Bio
  • Novogene
  • PTM BIO
  • BGI Genomics
  • Evotec
  • Metware Biotechnology
  • MRM Proteomics
  • Lc-Bio Technologies
  • Eurofins Scientific
  • MtoZ-Biolabs
  • Creative Proteomics
  • Macrogen
  • TATAA Biocenter
  • OmicScouts (Momentum Biotechnologies)
  • Precision Biomarker Laboratories (PBL)
  • Shanghai OE Biotech
  • RxCelerate
  • Proteomics International
  • Proteome Sciences
  • Westlake Omics
  • Crown Bioscience
  • VProteomics
  • Shanghai Majorbio Bio-Pharm
  • Applied Biomics
  • Sapient Bioanalytics
  • Allumiqs
  • MS Bioworks
  • Shanghai Bioprofile
  • Cosmos Wisdom
  • Olink (Thermo Fisher Scientific)
  • SomaLogic (Illumina)
  • Labcorp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Plasma and Serum Proteomics Analysis Service Market by Type
  3. 1.2.1 Global Plasma and Serum Proteomics Analysis Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Plasma Proteomics Analysis Service
  5. 1.2.3 Serum Proteomics Analysis Service
  6. 1.3 Plasma and Serum Proteomics Analysis Service Market by Application
  7. 1.3.1 Global Plasma and Serum Proteomics Analysis Service Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Disease Biomarker Research
  9. 1.3.3 Drug Development
  10. 1.3.4 Clinical Research
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Plasma and Serum Proteomics Analysis Service Market Dynamics
  1. 2.1 Plasma and Serum Proteomics Analysis Service Industry Trends
  2. 2.2 Plasma and Serum Proteomics Analysis Service Industry Drivers
  3. 2.3 Plasma and Serum Proteomics Analysis Service Industry Opportunities and Challenges
  4. 2.4 Plasma and Serum Proteomics Analysis Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Plasma and Serum Proteomics Analysis Service Market Perspective (2021-2032)
  2. 3.2 Global Plasma and Serum Proteomics Analysis Service Growth Trends by Region
  3. 3.2.1 Global Plasma and Serum Proteomics Analysis Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Plasma and Serum Proteomics Analysis Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Plasma and Serum Proteomics Analysis Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Plasma and Serum Proteomics Analysis Service Revenue by Players
  2. 4.1.1 Global Plasma and Serum Proteomics Analysis Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Plasma and Serum Proteomics Analysis Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Plasma and Serum Proteomics Analysis Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Plasma and Serum Proteomics Analysis Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Plasma and Serum Proteomics Analysis Service Key Players Headquarters & Area Served
  7. 4.4 Global Plasma and Serum Proteomics Analysis Service Players, Product Type & Application
  8. 4.5 Global Plasma and Serum Proteomics Analysis Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Plasma and Serum Proteomics Analysis Service Market CR5 and HHI
  11. 4.6.3 2025 Plasma and Serum Proteomics Analysis Service Tier 1, Tier 2, and Tier 3
5 Plasma and Serum Proteomics Analysis Service Market Size by Type
  1. 5.1 Global Plasma and Serum Proteomics Analysis Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Plasma and Serum Proteomics Analysis Service Revenue by Type (2021-2032)
  3. 5.3 Global Plasma and Serum Proteomics Analysis Service Revenue Market Share by Type (2021-2032)
6 Plasma and Serum Proteomics Analysis Service Market Size by Application
  1. 6.1 Global Plasma and Serum Proteomics Analysis Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Plasma and Serum Proteomics Analysis Service Revenue by Application (2021-2032)
  3. 6.3 Global Plasma and Serum Proteomics Analysis Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 BostonGene
  2. 7.1.1 BostonGene Company Information
  3. 7.1.2 BostonGene Business Overview
  4. 7.1.3 BostonGene Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 BostonGene Plasma and Serum Proteomics Analysis Service Product Portfolio
  6. 7.1.5 BostonGene Recent Developments
  7. 7.2 CellCarta
  8. 7.2.1 CellCarta Company Information
  9. 7.2.2 CellCarta Business Overview
  10. 7.2.3 CellCarta Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 CellCarta Plasma and Serum Proteomics Analysis Service Product Portfolio
  12. 7.2.5 CellCarta Recent Developments
  13. 7.3 GENEWIZ (Azenta Life Sciences)
  14. 7.3.1 GENEWIZ (Azenta Life Sciences) Company Information
  15. 7.3.2 GENEWIZ (Azenta Life Sciences) Business Overview
  16. 7.3.3 GENEWIZ (Azenta Life Sciences) Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 GENEWIZ (Azenta Life Sciences) Plasma and Serum Proteomics Analysis Service Product Portfolio
  18. 7.3.5 GENEWIZ (Azenta Life Sciences) Recent Developments
  19. 7.4 CDI Labs
  20. 7.4.1 CDI Labs Company Information
  21. 7.4.2 CDI Labs Business Overview
  22. 7.4.3 CDI Labs Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 CDI Labs Plasma and Serum Proteomics Analysis Service Product Portfolio
  24. 7.4.5 CDI Labs Recent Developments
  25. 7.5 Biognosys
  26. 7.5.1 Biognosys Company Information
  27. 7.5.2 Biognosys Business Overview
  28. 7.5.3 Biognosys Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Biognosys Plasma and Serum Proteomics Analysis Service Product Portfolio
  30. 7.5.5 Biognosys Recent Developments
  31. 7.6 Discovery Life Sciences
  32. 7.6.1 Discovery Life Sciences Company Information
  33. 7.6.2 Discovery Life Sciences Business Overview
  34. 7.6.3 Discovery Life Sciences Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Discovery Life Sciences Plasma and Serum Proteomics Analysis Service Product Portfolio
  36. 7.6.5 Discovery Life Sciences Recent Developments
  37. 7.7 Firalis Molecular Precision
  38. 7.7.1 Firalis Molecular Precision Company Information
  39. 7.7.2 Firalis Molecular Precision Business Overview
  40. 7.7.3 Firalis Molecular Precision Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Firalis Molecular Precision Plasma and Serum Proteomics Analysis Service Product Portfolio
  42. 7.7.5 Firalis Molecular Precision Recent Developments
  43. 7.8 Cell Signaling Technology (CST)
  44. 7.8.1 Cell Signaling Technology (CST) Company Information
  45. 7.8.2 Cell Signaling Technology (CST) Business Overview
  46. 7.8.3 Cell Signaling Technology (CST) Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Cell Signaling Technology (CST) Plasma and Serum Proteomics Analysis Service Product Portfolio
  48. 7.8.5 Cell Signaling Technology (CST) Recent Developments
  49. 7.9 Sampled (Infinity Biologix)
  50. 7.9.1 Sampled (Infinity Biologix) Company Information
  51. 7.9.2 Sampled (Infinity Biologix) Business Overview
  52. 7.9.3 Sampled (Infinity Biologix) Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Sampled (Infinity Biologix) Plasma and Serum Proteomics Analysis Service Product Portfolio
  54. 7.9.5 Sampled (Infinity Biologix) Recent Developments
  55. 7.10 APTBIO
  56. 7.10.1 APTBIO Company Information
  57. 7.10.2 APTBIO Business Overview
  58. 7.10.3 APTBIO Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 APTBIO Plasma and Serum Proteomics Analysis Service Product Portfolio
  60. 7.10.5 APTBIO Recent Developments
  61. 7.11 Sinotech Genomics
  62. 7.11.1 Sinotech Genomics Company Information
  63. 7.11.2 Sinotech Genomics Business Overview
  64. 7.11.3 Sinotech Genomics Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Sinotech Genomics Plasma and Serum Proteomics Analysis Service Product Portfolio
  66. 7.11.5 Sinotech Genomics Recent Developments
  67. 7.12 Biodesix
  68. 7.12.1 Biodesix Company Information
  69. 7.12.2 Biodesix Business Overview
  70. 7.12.3 Biodesix Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Biodesix Plasma and Serum Proteomics Analysis Service Product Portfolio
  72. 7.12.5 Biodesix Recent Developments
  73. 7.13 Panome Bio
  74. 7.13.1 Panome Bio Company Information
  75. 7.13.2 Panome Bio Business Overview
  76. 7.13.3 Panome Bio Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Panome Bio Plasma and Serum Proteomics Analysis Service Product Portfolio
  78. 7.13.5 Panome Bio Recent Developments
  79. 7.14 Novogene
  80. 7.14.1 Novogene Company Information
  81. 7.14.2 Novogene Business Overview
  82. 7.14.3 Novogene Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Novogene Plasma and Serum Proteomics Analysis Service Product Portfolio
  84. 7.14.5 Novogene Recent Developments
  85. 7.15 PTM BIO
  86. 7.15.1 PTM BIO Company Information
  87. 7.15.2 PTM BIO Business Overview
  88. 7.15.3 PTM BIO Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 PTM BIO Plasma and Serum Proteomics Analysis Service Product Portfolio
  90. 7.15.5 PTM BIO Recent Developments
  91. 7.16 BGI Genomics
  92. 7.16.1 BGI Genomics Company Information
  93. 7.16.2 BGI Genomics Business Overview
  94. 7.16.3 BGI Genomics Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 BGI Genomics Plasma and Serum Proteomics Analysis Service Product Portfolio
  96. 7.16.5 BGI Genomics Recent Developments
  97. 7.17 Evotec
  98. 7.17.1 Evotec Company Information
  99. 7.17.2 Evotec Business Overview
  100. 7.17.3 Evotec Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Evotec Plasma and Serum Proteomics Analysis Service Product Portfolio
  102. 7.17.5 Evotec Recent Developments
  103. 7.18 Metware Biotechnology
  104. 7.18.1 Metware Biotechnology Company Information
  105. 7.18.2 Metware Biotechnology Business Overview
  106. 7.18.3 Metware Biotechnology Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Metware Biotechnology Plasma and Serum Proteomics Analysis Service Product Portfolio
  108. 7.18.5 Metware Biotechnology Recent Developments
  109. 7.19 MRM Proteomics
  110. 7.19.1 MRM Proteomics Company Information
  111. 7.19.2 MRM Proteomics Business Overview
  112. 7.19.3 MRM Proteomics Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  113. 7.19.4 MRM Proteomics Plasma and Serum Proteomics Analysis Service Product Portfolio
  114. 7.19.5 MRM Proteomics Recent Developments
  115. 7.20 Lc-Bio Technologies
  116. 7.20.1 Lc-Bio Technologies Company Information
  117. 7.20.2 Lc-Bio Technologies Business Overview
  118. 7.20.3 Lc-Bio Technologies Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Lc-Bio Technologies Plasma and Serum Proteomics Analysis Service Product Portfolio
  120. 7.20.5 Lc-Bio Technologies Recent Developments
  121. 7.21 Eurofins Scientific
  122. 7.21.1 Eurofins Scientific Company Information
  123. 7.21.2 Eurofins Scientific Business Overview
  124. 7.21.3 Eurofins Scientific Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Eurofins Scientific Plasma and Serum Proteomics Analysis Service Product Portfolio
  126. 7.21.5 Eurofins Scientific Recent Developments
  127. 7.22 MtoZ-Biolabs
  128. 7.22.1 MtoZ-Biolabs Company Information
  129. 7.22.2 MtoZ-Biolabs Business Overview
  130. 7.22.3 MtoZ-Biolabs Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  131. 7.22.4 MtoZ-Biolabs Plasma and Serum Proteomics Analysis Service Product Portfolio
  132. 7.22.5 MtoZ-Biolabs Recent Developments
  133. 7.23 Creative Proteomics
  134. 7.23.1 Creative Proteomics Company Information
  135. 7.23.2 Creative Proteomics Business Overview
  136. 7.23.3 Creative Proteomics Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  137. 7.23.4 Creative Proteomics Plasma and Serum Proteomics Analysis Service Product Portfolio
  138. 7.23.5 Creative Proteomics Recent Developments
  139. 7.24 Macrogen
  140. 7.24.1 Macrogen Company Information
  141. 7.24.2 Macrogen Business Overview
  142. 7.24.3 Macrogen Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  143. 7.24.4 Macrogen Plasma and Serum Proteomics Analysis Service Product Portfolio
  144. 7.24.5 Macrogen Recent Developments
  145. 7.25 TATAA Biocenter
  146. 7.25.1 TATAA Biocenter Company Information
  147. 7.25.2 TATAA Biocenter Business Overview
  148. 7.25.3 TATAA Biocenter Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  149. 7.25.4 TATAA Biocenter Plasma and Serum Proteomics Analysis Service Product Portfolio
  150. 7.25.5 TATAA Biocenter Recent Developments
  151. 7.26 OmicScouts (Momentum Biotechnologies)
  152. 7.26.1 OmicScouts (Momentum Biotechnologies) Company Information
  153. 7.26.2 OmicScouts (Momentum Biotechnologies) Business Overview
  154. 7.26.3 OmicScouts (Momentum Biotechnologies) Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  155. 7.26.4 OmicScouts (Momentum Biotechnologies) Plasma and Serum Proteomics Analysis Service Product Portfolio
  156. 7.26.5 OmicScouts (Momentum Biotechnologies) Recent Developments
  157. 7.27 Precision Biomarker Laboratories (PBL)
  158. 7.27.1 Precision Biomarker Laboratories (PBL) Company Information
  159. 7.27.2 Precision Biomarker Laboratories (PBL) Business Overview
  160. 7.27.3 Precision Biomarker Laboratories (PBL) Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  161. 7.27.4 Precision Biomarker Laboratories (PBL) Plasma and Serum Proteomics Analysis Service Product Portfolio
  162. 7.27.5 Precision Biomarker Laboratories (PBL) Recent Developments
  163. 7.28 Shanghai OE Biotech
  164. 7.28.1 Shanghai OE Biotech Company Information
  165. 7.28.2 Shanghai OE Biotech Business Overview
  166. 7.28.3 Shanghai OE Biotech Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  167. 7.28.4 Shanghai OE Biotech Plasma and Serum Proteomics Analysis Service Product Portfolio
  168. 7.28.5 Shanghai OE Biotech Recent Developments
  169. 7.29 RxCelerate
  170. 7.29.1 RxCelerate Company Information
  171. 7.29.2 RxCelerate Business Overview
  172. 7.29.3 RxCelerate Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  173. 7.29.4 RxCelerate Plasma and Serum Proteomics Analysis Service Product Portfolio
  174. 7.29.5 RxCelerate Recent Developments
  175. 7.30 Proteomics International
  176. 7.30.1 Proteomics International Company Information
  177. 7.30.2 Proteomics International Business Overview
  178. 7.30.3 Proteomics International Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  179. 7.30.4 Proteomics International Plasma and Serum Proteomics Analysis Service Product Portfolio
  180. 7.30.5 Proteomics International Recent Developments
  181. 7.31 Proteome Sciences
  182. 7.31.1 Proteome Sciences Company Information
  183. 7.31.2 Proteome Sciences Business Overview
  184. 7.31.3 Proteome Sciences Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  185. 7.31.4 Proteome Sciences Plasma and Serum Proteomics Analysis Service Product Portfolio
  186. 7.31.5 Proteome Sciences Recent Developments
  187. 7.32 Westlake Omics
  188. 7.32.1 Westlake Omics Company Information
  189. 7.32.2 Westlake Omics Business Overview
  190. 7.32.3 Westlake Omics Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  191. 7.32.4 Westlake Omics Plasma and Serum Proteomics Analysis Service Product Portfolio
  192. 7.32.5 Westlake Omics Recent Developments
  193. 7.33 Crown Bioscience
  194. 7.33.1 Crown Bioscience Company Information
  195. 7.33.2 Crown Bioscience Business Overview
  196. 7.33.3 Crown Bioscience Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  197. 7.33.4 Crown Bioscience Plasma and Serum Proteomics Analysis Service Product Portfolio
  198. 7.33.5 Crown Bioscience Recent Developments
  199. 7.34 VProteomics
  200. 7.34.1 VProteomics Company Information
  201. 7.34.2 VProteomics Business Overview
  202. 7.34.3 VProteomics Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  203. 7.34.4 VProteomics Plasma and Serum Proteomics Analysis Service Product Portfolio
  204. 7.34.5 VProteomics Recent Developments
  205. 7.35 Shanghai Majorbio Bio-Pharm
  206. 7.35.1 Shanghai Majorbio Bio-Pharm Company Information
  207. 7.35.2 Shanghai Majorbio Bio-Pharm Business Overview
  208. 7.35.3 Shanghai Majorbio Bio-Pharm Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  209. 7.35.4 Shanghai Majorbio Bio-Pharm Plasma and Serum Proteomics Analysis Service Product Portfolio
  210. 7.35.5 Shanghai Majorbio Bio-Pharm Recent Developments
  211. 7.36 Applied Biomics
  212. 7.36.1 Applied Biomics Company Information
  213. 7.36.2 Applied Biomics Business Overview
  214. 7.36.3 Applied Biomics Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  215. 7.36.4 Applied Biomics Plasma and Serum Proteomics Analysis Service Product Portfolio
  216. 7.36.5 Applied Biomics Recent Developments
  217. 7.37 Sapient Bioanalytics
  218. 7.37.1 Sapient Bioanalytics Company Information
  219. 7.37.2 Sapient Bioanalytics Business Overview
  220. 7.37.3 Sapient Bioanalytics Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  221. 7.37.4 Sapient Bioanalytics Plasma and Serum Proteomics Analysis Service Product Portfolio
  222. 7.37.5 Sapient Bioanalytics Recent Developments
  223. 7.38 Allumiqs
  224. 7.38.1 Allumiqs Company Information
  225. 7.38.2 Allumiqs Business Overview
  226. 7.38.3 Allumiqs Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  227. 7.38.4 Allumiqs Plasma and Serum Proteomics Analysis Service Product Portfolio
  228. 7.38.5 Allumiqs Recent Developments
  229. 7.39 MS Bioworks
  230. 7.39.1 MS Bioworks Company Information
  231. 7.39.2 MS Bioworks Business Overview
  232. 7.39.3 MS Bioworks Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  233. 7.39.4 MS Bioworks Plasma and Serum Proteomics Analysis Service Product Portfolio
  234. 7.39.5 MS Bioworks Recent Developments
  235. 7.40 Shanghai Bioprofile
  236. 7.40.1 Shanghai Bioprofile Company Information
  237. 7.40.2 Shanghai Bioprofile Business Overview
  238. 7.40.3 Shanghai Bioprofile Plasma and Serum Proteomics Analysis Service Revenue and Gross Margin (2021-2026)
  239. 7.40.4 Shanghai Bioprofile Plasma and Serum Proteomics Analysis Service Product Portfolio
  240. 7.40.5 Shanghai Bioprofile Recent Developments
  241. 7.41 Cosmos Wisdom
  242. 7.42 Olink (Thermo Fisher Scientific)
  243. 7.43 SomaLogic (Illumina)
  244. 7.44 Labcorp
8 North America
  1. 8.1 North America Plasma and Serum Proteomics Analysis Service Revenue (2021-2032)
  2. 8.2 North America Plasma and Serum Proteomics Analysis Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Plasma and Serum Proteomics Analysis Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Plasma and Serum Proteomics Analysis Service Revenue by Type (2027-2032)
  5. 8.3 North America Plasma and Serum Proteomics Analysis Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Plasma and Serum Proteomics Analysis Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Plasma and Serum Proteomics Analysis Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Plasma and Serum Proteomics Analysis Service Revenue by Application (2027-2032)
  9. 8.5 North America Plasma and Serum Proteomics Analysis Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Plasma and Serum Proteomics Analysis Service Revenue by Country
  11. 8.6.1 North America Plasma and Serum Proteomics Analysis Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Plasma and Serum Proteomics Analysis Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Plasma and Serum Proteomics Analysis Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Plasma and Serum Proteomics Analysis Service Revenue (2021-2032)
  2. 9.2 Europe Plasma and Serum Proteomics Analysis Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Plasma and Serum Proteomics Analysis Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Plasma and Serum Proteomics Analysis Service Revenue by Type (2027-2032)
  5. 9.3 Europe Plasma and Serum Proteomics Analysis Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Plasma and Serum Proteomics Analysis Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Plasma and Serum Proteomics Analysis Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Plasma and Serum Proteomics Analysis Service Revenue by Application (2027-2032)
  9. 9.5 Europe Plasma and Serum Proteomics Analysis Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Plasma and Serum Proteomics Analysis Service Revenue by Country
  11. 9.6.1 Europe Plasma and Serum Proteomics Analysis Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Plasma and Serum Proteomics Analysis Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Plasma and Serum Proteomics Analysis Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Plasma and Serum Proteomics Analysis Service Revenue (2021-2032)
  2. 10.2 China Plasma and Serum Proteomics Analysis Service Revenue by Type (2021-2032)
  3. 10.2.1 China Plasma and Serum Proteomics Analysis Service Revenue by Type (2021-2026)
  4. 10.2.2 China Plasma and Serum Proteomics Analysis Service Revenue by Type (2027-2032)
  5. 10.3 China Plasma and Serum Proteomics Analysis Service Revenue Share by Type (2021-2032)
  6. 10.4 China Plasma and Serum Proteomics Analysis Service Revenue by Application (2021-2032)
  7. 10.4.1 China Plasma and Serum Proteomics Analysis Service Revenue by Application (2021-2026)
  8. 10.4.2 China Plasma and Serum Proteomics Analysis Service Revenue by Application (2027-2032)
  9. 10.5 China Plasma and Serum Proteomics Analysis Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Plasma and Serum Proteomics Analysis Service Revenue (2021-2032)
  2. 11.2 Asia Plasma and Serum Proteomics Analysis Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Plasma and Serum Proteomics Analysis Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Plasma and Serum Proteomics Analysis Service Revenue by Type (2027-2032)
  5. 11.3 Asia Plasma and Serum Proteomics Analysis Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Plasma and Serum Proteomics Analysis Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Plasma and Serum Proteomics Analysis Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Plasma and Serum Proteomics Analysis Service Revenue by Application (2027-2032)
  9. 11.5 Asia Plasma and Serum Proteomics Analysis Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Plasma and Serum Proteomics Analysis Service Revenue by Country
  11. 11.6.1 Asia Plasma and Serum Proteomics Analysis Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Plasma and Serum Proteomics Analysis Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Plasma and Serum Proteomics Analysis Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Plasma and Serum Proteomics Analysis Service Revenue (2021-2032)
  2. 12.2 SAMEA Plasma and Serum Proteomics Analysis Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Plasma and Serum Proteomics Analysis Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Plasma and Serum Proteomics Analysis Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Plasma and Serum Proteomics Analysis Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Plasma and Serum Proteomics Analysis Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Plasma and Serum Proteomics Analysis Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Plasma and Serum Proteomics Analysis Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Plasma and Serum Proteomics Analysis Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Plasma and Serum Proteomics Analysis Service Revenue by Country
  11. 12.6.1 SAMEA Plasma and Serum Proteomics Analysis Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Plasma and Serum Proteomics Analysis Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Plasma and Serum Proteomics Analysis Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst